Sailaja Puttagunta

Statistics

Publications

Citations

2.5K

H-Index

Active since

1994

Affiliations

Fulcrum Therapeutics (United States)(Current)

Allergan (United States)

Institute for Clinical Pharmacodynamics (United States)

Weizmann Institute of Science

West County Health Centers

Sailaja Puttagunta is an author at Fulcrum Therapeutics (United States) specializing in pharmacology, antimicrobial pharmacotherapy, and clinical pharmacology.

Publications per year

1994–2025

Publications

Targeted suppression of human IBD-associated gut microbiota commensals by phage consortia for treatment of intestinal inflammation

Sara Federici, Sharon Kredo‐Russo, Rafael Valdés‐Mas et al. · Cell · 2022 · 509 citations · Full text

Life Sciences, Immunology, Microbiology +16

Once-Weekly Dalbavancin versus Daily Conventional Therapy for Skin Infection

Helen W. Boucher, Mark Wilcox, George H. Talbot et al. · New England Journal of Medicine · 2014 · 425 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Extended-Duration Dosing and Distribution of Dalbavancin into Bone and Articular Tissue

Michael W. Dunne, Sailaja Puttagunta, Craig R. Sprenger et al. · Antimicrobial Agents and Chemotherapy · 2015 · 228 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

A Randomized Clinical Trial of Single-Dose Versus Weekly Dalbavancin for Treatment of Acute Bacterial Skin and Skin Structure Infection

Michael W. Dunne, Sailaja Puttagunta, Philip Giordano et al. · Clinical Infectious Diseases · 2015 · 214 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Dalbavancin for the Treatment of Osteomyelitis in Adult Patients: A Randomized Clinical Trial of Efficacy and Safety

Urania Rappo, Sailaja Puttagunta, V. G. Shevchenko et al. · Open Forum Infectious Diseases · 2018 · 207 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

1–5 of 29